WebAug 27, 2012 · Here we show that DEC-205, a multilectin receptor expressed by a variety of cells, is a receptor for CpG ODN. When CpG ODN are used as an adjuvant, mice deficient in DEC-205 have impaired dendritic cell (DC) and B-cell maturation, are unable to make some cytokines such as IL-12, and display suboptimal cytotoxic T-cell responses. WebDec 19, 2003 · 2A shows an IFN-α dose response of typical B-Class (2006), C-Class (2395), A-Class (2216) and control ODN 2243 (2216 GC) or 1982 (non-CpG ODN). The B-Class ODN stimulated low IFN-α levels compared to the C- or A-Class ODN. IFN-α induced by the A-Class ODN (2216; or 2336 not shown) exceeded that induced by the C-Class ODN.
Activation with CpG-A and CpG-B oligonucleotides …
WebMar 11, 2024 · FSC/SSChighCD4highNKp46+ cells produced high levels of IFN-α after CpG ODN 2216 stimulation, a hallmark of pDC function. Following receptor triggering with plate-bound monoclonal antibodies against NKp46, phosphorylation of signaling molecules downstream of NKp46 was analyzed in pDCs and NK cells. Comparable to NK cells, … WebODN 2216 is a Class-A CpG ODN that preferentially binds to human TLR9. Class A CpG ODNs are characterized by a phosphodiester central CpG-containing palindromic motif … raneri \\u0026 long roofing
CpG ODN2216 increases monocyte expression of CD80, CD86 …
WebODN 2006-Type B, human TLR9 agonist, FITC conjugate, oligodeoxy nucleotide vaccine adjuvant. CpG: 50 µg: $958.00: VAdv-Ly0047: ODN 2216-Type A (human, Biotin Conjugate) ODN 2216-Type A, human TLR9 agonist, biotin conjugate, oligodeoxy nucleotide vaccine adjuvant. CpG: 50 µg: $958.00: VAdv-Ly0048: ODN 2216-Type A (human, FITC Conjugate) WebSep 1, 2015 · In this study, we constructed a plasmid (pL-CpGmix) that harbors multiple copies of CpG-ODN 2216 (class A), 1668 (class B), and 2395 (class C) motifs, and evaluated the potential of the constructed plasmid to protect of olive flounder ( Paralichthys olivaceus) from viral hemorrhagic septicemia virus (VHSV) and Miamiensis avidus … WebMar 5, 2004 · ( E) PMBCs, CD123-depleted PMBCs, and CD123-enriched PBMCs were stimulated as in (C) and with 1 μM CpG-ODN 2216 and were tested for IFN-α secretion. One representative experiment of at least two independent experiments with two different donors is shown ( n = 2, ± SD). Open in viewer owb health